Table 1.

Percent of cell-type distribution before and after CD16 MACS of human granulocyte suspensions

Before MACSCD16+CD16
Control (n = 7) CML (n = 7) Control (n = 8) CML (n = 11) Control (n = 7) CML (n = 6)
Neutrophils  92.1 ± 2.1 90.1 ± 4.3  99.1 ± 0.4  99.5 ± 0.3 10.7 ± 8.2  17.0 ± 5.2  
Eosinophils  6.1 ± 1.6 7.0 ± 3.8  0  0  78.4 ± 9.7 63.2 ± 13.9  
Basophils  0  0.7 ± 0.5 0.1 ± 0.1  0.1 ± 0.1  0  2.7 ± 1.8 
Lymphocytes  1.6 ± 0.8  1.1 ± 0.7  0.5 ± 0.3 0.2 ± 0.1  10.0 ± 6.8  4.0 ± 1.4  
Monocytes 0.1 ± 0.2  0.4 ± 0.2  0  0.1 ± 0.1 0.7 ± 0.5  0.8 ± 0.5  
Metamyelocytes  0.1 ± 0.2  0.1 ± 0.1  0  0.1 ± 0.2 2.0 ± 1.1  
Myelocytes  0  0.4 ± 0.3 0.1 ± 0.1  0.1 ± 0.1  0  7.9 ± 4.5 
Promyelocytes  0  0  0  0  1.8 ± 1.1  
Blasts  0  0  0.1 ± 0.1  0.7 ± 0.7 
Before MACSCD16+CD16
Control (n = 7) CML (n = 7) Control (n = 8) CML (n = 11) Control (n = 7) CML (n = 6)
Neutrophils  92.1 ± 2.1 90.1 ± 4.3  99.1 ± 0.4  99.5 ± 0.3 10.7 ± 8.2  17.0 ± 5.2  
Eosinophils  6.1 ± 1.6 7.0 ± 3.8  0  0  78.4 ± 9.7 63.2 ± 13.9  
Basophils  0  0.7 ± 0.5 0.1 ± 0.1  0.1 ± 0.1  0  2.7 ± 1.8 
Lymphocytes  1.6 ± 0.8  1.1 ± 0.7  0.5 ± 0.3 0.2 ± 0.1  10.0 ± 6.8  4.0 ± 1.4  
Monocytes 0.1 ± 0.2  0.4 ± 0.2  0  0.1 ± 0.1 0.7 ± 0.5  0.8 ± 0.5  
Metamyelocytes  0.1 ± 0.2  0.1 ± 0.1  0  0.1 ± 0.2 2.0 ± 1.1  
Myelocytes  0  0.4 ± 0.3 0.1 ± 0.1  0.1 ± 0.1  0  7.9 ± 4.5 
Promyelocytes  0  0  0  0  1.8 ± 1.1  
Blasts  0  0  0.1 ± 0.1  0.7 ± 0.7 

CD16+ neutrophils and eosinophil-enriched CD16 cell suspensions were prepared by MACS of the granulocyte fractions from CML patients and healthy controls. Duplicate cytocentrifugation slides were prepared from each cell fraction and stained with May-Grünwald-Giemsa. Thereafter, differential counting of a total of 200 cells per slide (ie, 400 cells per cell fraction from each individual) was performed. The numbers indicate percentage ± SEM of nucleated cells.

or Create an Account

Close Modal
Close Modal